{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:16:39Z","timestamp":1788401799966,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1U01AI068636"],"award-info":[{"award-number":["1U01AI068636"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Papillomavirus Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pvr.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T01:34:04Z","timestamp":1534383244000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1"],"prefix":"10.1016","volume":"6","author":[{"given":"Michelle S.","family":"Cespedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna Milunka","family":"Kojic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triin","family":"Umbleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Webster-Cyriaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Masih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Firnhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Saah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Cu-Uvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Aberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pvr.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/COH.0000000000000336","article-title":"Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era","author":"Palefsky","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","author":"Piketty","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pvr.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0140-6736(91)91233-K","article-title":"Aetiological parallel between anal cancer and cervical cancer","author":"Melbye","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pvr.2018.08.002_bib5","first-page":"212","article-title":"Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer","author":"Ogunbiyi","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.pvr.2018.08.002_bib6","first-page":"1","article-title":"Anal cancer in renal transplant patients","author":"Patel","year":"2007","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2018.08.002_bib8","first-page":"1915","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","author":"Future II Study Group","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cid\/ciu238","article-title":"Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women","author":"Kojic","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib10","article-title":"High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era","author":"Hidalgo-Tenorio","year":"2017","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.pvr.2018.08.002_bib11","first-page":"258","article-title":"Human papillomavirus-associated cancers - United States, 2004\u20132008","author":"Center for Disease Control and Prevention (CDC)","year":"2012","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.pvr.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","author":"Clifford","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pvr.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","author":"Engels","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2018.08.002_bib14","first-page":"543","article-title":"Anal dysplasia in HIV-infected women: a commentary on the field","author":"Godfrey","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003","author":"Patel","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pvr.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/QAI.0000000000001300","article-title":"Prevalence of anal HPV and anal dysplasia in HIV-infected women from Johannesburg, South Africa","author":"Goeieman","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pvr.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","author":"Lin","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/cid\/civ049","article-title":"High prevalence of anal human Papillomavirus-associated cancer precursors in a contemporary cohort of asymptomatic HIV-infected women","author":"Heard","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States","author":"Robbins","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America","author":"Silverberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/QAD.0000000000000382","article-title":"Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort","author":"Hleyhel","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","author":"Palefsky","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib23","first-page":"43","article-title":"Evaluation of the Long-term anti-human papillomavirus 6 (HPV6), 11, 16, and 18 immune responses generated by the quadrivalent HPV vaccine","author":"Nygard","year":"2015","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.pvr.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.4161\/hv.36121","article-title":"Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine and HPV-6\/11\/16\/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a phase III randomized trial","author":"Einstein","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.pvr.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4161\/hv.29532","article-title":"Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination","author":"Naud","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.pvr.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/656320","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men","author":"Wilkin","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2018.05.001","article-title":"A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men","author":"Ellsworth","year":"2018","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.pvr.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"e0176422","DOI":"10.1371\/journal.pone.0176422","article-title":"The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results","author":"Volpini","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0956462415587226","article-title":"Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India","author":"Menezes","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.pvr.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/OLQ.0b013e3181f70253","article-title":"Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV\/AIDS in the era of effective therapy (the sun study)","author":"Kojic","year":"2011","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/infdis\/jiv751","article-title":"Prevalence of and risk factors for anal oncogenic human papillomavirus infection among HIV-infected women in france in the combination antiretroviral therapy era","author":"Heard","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","author":"Lin","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/cix135","article-title":"Carcinogenicity of human Papillomavirus(HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer","author":"Clifford","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib34","first-page":"e1","article-title":"Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women","author":"Massad","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pvr.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/jiv403","article-title":"Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005\u20132006","author":"Liu","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib37","article-title":"Gender-neutral vaccination provides improved control of human papillomavirus types 18\/31\/33\/35 through herd immunity: results of a community randomised trial (III)","author":"Lehtinen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.pvr.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination","author":"Machalek","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pvr.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"e0185423","DOI":"10.1371\/journal.pone.0185423","article-title":"Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women","author":"Travassos","year":"2017","journal-title":"PLoS One"}],"container-title":["Papillomavirus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852118300405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852118300405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:02:33Z","timestamp":1762513353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405852118300405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":40,"alternative-id":["S2405852118300405"],"URL":"https:\/\/doi.org\/10.1016\/j.pvr.2018.08.002","relation":{},"ISSN":["2405-8521"],"issn-type":[{"value":"2405-8521","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1","name":"articletitle","label":"Article Title"},{"value":"Papillomavirus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pvr.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}